Cargando…
Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
Recently, specific immunometabolic profiles have been postulated in patients with schizophrenia, even before full-blown disease and independent of antipsychotic treatment. Proteomic profiling studies offer a promising potential for elucidating the cellular and molecular pathways that may be involved...
Autores principales: | Borovcanin, Milica M, Vesic, Katarina, Jovanovic, Milena, Mijailovic, Natasa R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554363/ https://www.ncbi.nlm.nih.gov/pubmed/34754374 http://dx.doi.org/10.4239/wjd.v12.i10.1731 |
Ejemplares similares
-
Neuroimmune, clinical and treatment challenges in multiple sclerosis-related psychoses
por: Vesic, Katarina, et al.
Publicado: (2023) -
Breast cancer in schizophrenia could be interleukin-33-mediated
por: Borovcanin, Milica M, et al.
Publicado: (2021) -
Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations
por: Mijailović, Nataša R., et al.
Publicado: (2022) -
Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
por: Borovcanin, Milica M., et al.
Publicado: (2022) -
The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction
por: Mijailovic, Natasa R., et al.
Publicado: (2022)